Translational Genomics Research Institute

33°27′10.68″N 112°4′1.83″W

Translational Genomics Research Institute

Company type	Research Institute
Industry	Genomics
Founded	July 2002, Phoenix, Arizona, United States
Headquarters	Phoenix, Arizona, United States
Key people	Jeffrey Trent[1]
Revenue	$51.7 million (2007)[2] $18.3 million (2003)[2]
Total assets	24,398,471 United States dollar (2022)
Number of employees	258 (2008)[2]
Website	www.tgen.org

The Translational Genomics Research Institute at night

The Translational Genomics Research Institute (TGen) is a non-profit genomics research institute based in Phoenix, Arizona, United States.

History and activities

TGen was established in July 2002 by Jeffrey Trent in Phoenix, Arizona, with an initial investment of US$100 million from Arizona public- and private-sector investors.^[2]

The field of translational genomics research searches for ways to apply results from the Human Genome Project to the development of improved diagnostics, prognostics, and therapies for cancer, neurological disorders, diabetes and other complex diseases.

The mission of TGen is to make and translate genomic discoveries into advances in human health.^[3] TGen has contributed to the growth of scientific research and biotechnology in Arizona. The institute has been involved in collaborations and studies, such as the research on chronic traumatic encephalopathy (CTE) in former NFL players in partnership with Exosome Sciences.^[4]